https://www.eccvid.org/ 2026-02-03T13:09:32Z https://www.eccvid.org/exhibition 2026-02-03T13:09:33Z https://www.eccvid.org/login 2026-02-03T13:09:33Z https://www.eccvid.org/media-668-illumina-global-response-to-covid-19 2026-02-03T13:09:32Z https://www.eccvid.org/media-680-bd-diagnostics---advancing-covid-19-diagnostic-innovation-across-the-testing-pathway-a-scientific-expert-panel-discussion-with-live-qa 2026-02-03T13:09:33Z https://www.eccvid.org/media-734-biomérieux---the-role-of-diagnostic-solutions-for-covid-19-patients-diagnostics--prognosis--complications-and-follow-up 2026-02-03T13:09:33Z https://www.eccvid.org/media-742-quidel---managing-scarcity-effective-algorithms-incorporating-innovative-technologies-for-administering-covid-19-diagnostic-testing-in-the-hospitals-and-community 2026-02-03T13:09:33Z https://www.eccvid.org/media-753-beckman-coulter-life-sciences---recognizing-the-immune-response-to-sars-cov-2 2026-02-03T13:09:32Z https://www.eccvid.org/media-763-abbott---testing-patients-suspected-of-covid-19-clinicians-from-ny-and-rio-de-janeiro-share-their-perspectives 2026-02-03T13:09:33Z https://www.eccvid.org/media-765-seegene---clinical-validation-and-cases-of-using-seegene-covid-19-real-time-pcr-product 2026-02-03T13:09:32Z https://www.eccvid.org/media-767-astrazeneca---targeting-sars-cov-2-novel-vaccines-and-antivirals-for-the-prevention-and-treatment-of-covid-19 2026-02-03T13:09:32Z https://www.eccvid.org/media-784-thermofisher---current-challenges--learning-to-advance-antibiotic-stewardship-in-the-wake-of-coronavirus 2026-02-03T13:09:33Z https://www.eccvid.org/media-816-pfizer---covid-19-secondary-infections-understanding-the-threat-of-opportunistic-bacteria-and-fungi 2026-02-03T13:09:32Z https://www.eccvid.org/mentions-legales 2026-02-03T13:09:32Z https://www.eccvid.org/speaker-list 2026-02-03T13:09:33Z https://www.eccvid.org/ubiquity-1625-industry-sessions---03122020 2026-02-03T13:09:33Z